Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid: Difference between revisions
Jump to navigation
Jump to search
(/* Antioxidant Vitamins and Folic Acid (DO NOT EDIT){{cite journal| author=Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE et al.| title=2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Managemen...) |
|||
Line 10: | Line 10: | ||
|colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] | |colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] | ||
|- | |- | ||
|bgcolor="LightCoral"| | |bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' Antioxidant vitamin supplements (e.g., [[vitamin E]], [[vitamin C]], or [[beta carotene]]) should not be used for secondary prevention in [[UA]] / [[NSTEMI]] patients. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | ||
<nowiki>"</nowiki>'''1.''' Antioxidant vitamin supplements (e.g., [[vitamin E]], [[vitamin C]], or [[beta carotene]]) should not be used for secondary prevention in [[UA]] / [[NSTEMI]] patients. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | |||
|- | |- | ||
|bgcolor="LightCoral"| | |bgcolor="LightCoral"|<nowiki>"</nowiki>'''2.''' [[Folic acid]], with or without [[vitamin B6]] and [[vitamin B12]], should not be used for secondary prevention in [[UA]] / [[NSTEMI]] patients. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | ||
<nowiki>"</nowiki>'''2.''' [[Folic acid]], with or without [[vitamin B6]] and [[vitamin B12]], should not be used for secondary prevention in [[UA]] / [[NSTEMI]] patients. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | |||
|} | |} | ||
Revision as of 13:43, 2 November 2012
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non -ST-Elevation Myocardial Infarction (DO NOT EDIT)[1]
Antioxidant Vitamins and Folic Acid (DO NOT EDIT)[1]
Class III |
"1. Antioxidant vitamin supplements (e.g., vitamin E, vitamin C, or beta carotene) should not be used for secondary prevention in UA / NSTEMI patients. (Level of Evidence: A)" |
"2. Folic acid, with or without vitamin B6 and vitamin B12, should not be used for secondary prevention in UA / NSTEMI patients. (Level of Evidence: A)" |
See Also
References
- ↑ 1.0 1.1 Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE; et al. (2011). "2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 123 (18): e426–579. doi:10.1161/CIR.0b013e318212bb8b. PMID 21444888.